• Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 16 Nov 2024 03:01:19   America/Chicago


    Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Rating of "Moderate Buy" from Brokerages Written by MarketBeat November 16, 2024 Share Link copied to clipboard. Shares of Intellia Therapeutics, Inc.
    Read more...
Share on,